Triggering of the TLR2/MyD88 signaling pathway by TEV derived from thymoma, mammary carcinoma or colon carcinoma cells and containing HSP72, has been shown to induce IL-6 production by MDSC and autocrine activation of STAT3 [145]. The gene discussed is IL6; the disease is breast carcinoma.